Glycosylation Signatures of Inflammation Identify Cardiovascular Risk: Some Glyc It Hot.

about

Glycosylation Profile of Immunoglobulin G Is Cross-Sectionally Associated With Cardiovascular Disease Risk Score and Subclinical Atherosclerosis in Two Independent Cohorts.

P2860

Q55420505-6D8841D5-091E-45CD-A2A2-D694677C8CAF

P2860

Glycosylation Signatures of Inflammation Identify Cardiovascular Risk: Some Glyc It Hot.

Item

http://www.wikidata.org/entity/Q43288683

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Glycosylation Signatures of Inflammation Identify Cardiovascular Risk: Some Glyc It Hot.

@en

Glycosylation Signatures of Inflammation Identify Cardiovascular Risk: Some Glyc It Hot.

@nl

type

Item

label

Glycosylation Signatures of Inflammation Identify Cardiovascular Risk: Some Glyc It Hot.

@en

Glycosylation Signatures of Inflammation Identify Cardiovascular Risk: Some Glyc It Hot.

@nl

prefLabel

Glycosylation Signatures of Inflammation Identify Cardiovascular Risk: Some Glyc It Hot.

@en

Glycosylation Signatures of Inflammation Identify Cardiovascular Risk: Some Glyc It Hot.

@nl

P1476

Glycosylation Signatures of Inflammation Identify Cardiovascular Risk: Some Glyc It Hot.

@en

P2093

Samia Mora

http://www.w3.org/2001/XMLSchema#string

P2860

Biomarker profiling by nuclear magnetic resonance spectroscopy for the prediction of all-cause mortality: an observational study of 17,345 persons

Inflammatory glycoproteins in cardiometabolic disorders, autoimmune diseases and cancer

Progress and challenges in translating the biology of atherosclerosis

A novel protein glycan biomarker and future cardiovascular disease events.

The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis.

Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts.

Novel protein glycan side-chain biomarker and risk of incident type 2 diabetes mellitus.

Circulating N-Linked Glycoprotein Acetyls and Longitudinal Mortality Risk.

Circulating N-Linked Glycoprotein Side-Chain Biomarker, Rosuvastatin Therapy, and Incident Cardiovascular Disease: An Analysis From the JUPITER Trial.

GlycA: A Composite Nuclear Magnetic Resonance Biomarker of Systemic Inflammation.

P304

1154-1156

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1161/CIRCRESAHA.116.310005

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

119

http://www.w3.org/2001/XMLSchema#string

P50

Patrick Lawler

P577

2016-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28051777

http://www.w3.org/2001/XMLSchema#string

P921

glycosylation

P932

5215843

http://www.w3.org/2001/XMLSchema#string

Glycosylation Signatures of Inflammation Identify Cardiovascular Risk: Some Glyc It Hot.

about

P2860

P2860

Glycosylation Signatures of Inflammation Identify Cardiovascular Risk: Some Glyc It Hot.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932